AxoGen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.81 Billion, with shareholders equity totaling $128.85 Millions.
The company employs approximately 368 people and operates in the Health sector, within the Medical Supplies and Equipment industry.
Over the past 12 months, AxoGen Inc. reported $225.20 Millions in revenue, generating net income of $-15.70 Millions.
Key financial metrics include a P/E ratio of -115.00, a price-to-book (P/B) ratio of 14.01, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker AXGN.